The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review

Antonio Polito, Miriam Isola, Paolo Lanzetta, Dario Gregori, Francesco Bandello

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Introduction: The purpose of this review is to combine the results of existing literature on the natural history of occult choroidal neovascularisation (CNV) associated with age-related macular degeneration (AMD). Materials and Methods: Published reports evaluating eyes with occult CNV in AMD patients were selected for meta-analysis based on a computerised MEDLINE search. Pooled estimates of the proportions of eyes with a vision loss greater than 2 to 3 (moderate vision loss) or 6 lines (severe vision loss) at 1 year and 2 to 3 years, respectively, or developing a classic component on fluorescein angiography at 1 year were measured. Results: There is no significant heterogeneity among published rates of visual loss and development of classic CNV. The overall pooled estimates (95% confidence limits) of the proportions of eyes with at least moderate or severe vision loss, respectively, were 59% (53% to 64.5%) and 34% (25% to 43%) at 1 year and 70% (64% to 76%) and 47% (40% to 54%) at 2 to 3 years; the overall pooled estimate of the percentage of eyes developing classic CNV at 1 year was 46% (39% to 54%). Conclusion: A substantial number of patients with occult CNV from AMD will develop at least moderate visual loss at 1 year and severe visual loss within 3 years. However, visual acuity may remain stable in up to 30% of patients. These results may help us to understand the exact role of new therapies and in planning future trials.

Original languageEnglish
Pages (from-to)145-150
Number of pages6
JournalAnnals of the Academy of Medicine Singapore
Volume35
Issue number3
Publication statusPublished - Mar 2006

Fingerprint

Choroidal Neovascularization
Macular Degeneration
Fluorescein Angiography
MEDLINE
Visual Acuity
Meta-Analysis

Keywords

  • Age-related maculopathy
  • Fluorescein angiography
  • Meta-analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review. / Polito, Antonio; Isola, Miriam; Lanzetta, Paolo; Gregori, Dario; Bandello, Francesco.

In: Annals of the Academy of Medicine Singapore, Vol. 35, No. 3, 03.2006, p. 145-150.

Research output: Contribution to journalArticle

@article{8e7af7df7d124b49bdc87bdee1d7843e,
title = "The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review",
abstract = "Introduction: The purpose of this review is to combine the results of existing literature on the natural history of occult choroidal neovascularisation (CNV) associated with age-related macular degeneration (AMD). Materials and Methods: Published reports evaluating eyes with occult CNV in AMD patients were selected for meta-analysis based on a computerised MEDLINE search. Pooled estimates of the proportions of eyes with a vision loss greater than 2 to 3 (moderate vision loss) or 6 lines (severe vision loss) at 1 year and 2 to 3 years, respectively, or developing a classic component on fluorescein angiography at 1 year were measured. Results: There is no significant heterogeneity among published rates of visual loss and development of classic CNV. The overall pooled estimates (95{\%} confidence limits) of the proportions of eyes with at least moderate or severe vision loss, respectively, were 59{\%} (53{\%} to 64.5{\%}) and 34{\%} (25{\%} to 43{\%}) at 1 year and 70{\%} (64{\%} to 76{\%}) and 47{\%} (40{\%} to 54{\%}) at 2 to 3 years; the overall pooled estimate of the percentage of eyes developing classic CNV at 1 year was 46{\%} (39{\%} to 54{\%}). Conclusion: A substantial number of patients with occult CNV from AMD will develop at least moderate visual loss at 1 year and severe visual loss within 3 years. However, visual acuity may remain stable in up to 30{\%} of patients. These results may help us to understand the exact role of new therapies and in planning future trials.",
keywords = "Age-related maculopathy, Fluorescein angiography, Meta-analysis",
author = "Antonio Polito and Miriam Isola and Paolo Lanzetta and Dario Gregori and Francesco Bandello",
year = "2006",
month = "3",
language = "English",
volume = "35",
pages = "145--150",
journal = "Annals of the Academy of Medicine, Singapore",
issn = "0304-4602",
publisher = "Academy of Medicine Singapore",
number = "3",

}

TY - JOUR

T1 - The natural history of occult choroidal neovascularisation associated with age-related macular degeneration. A systematic review

AU - Polito, Antonio

AU - Isola, Miriam

AU - Lanzetta, Paolo

AU - Gregori, Dario

AU - Bandello, Francesco

PY - 2006/3

Y1 - 2006/3

N2 - Introduction: The purpose of this review is to combine the results of existing literature on the natural history of occult choroidal neovascularisation (CNV) associated with age-related macular degeneration (AMD). Materials and Methods: Published reports evaluating eyes with occult CNV in AMD patients were selected for meta-analysis based on a computerised MEDLINE search. Pooled estimates of the proportions of eyes with a vision loss greater than 2 to 3 (moderate vision loss) or 6 lines (severe vision loss) at 1 year and 2 to 3 years, respectively, or developing a classic component on fluorescein angiography at 1 year were measured. Results: There is no significant heterogeneity among published rates of visual loss and development of classic CNV. The overall pooled estimates (95% confidence limits) of the proportions of eyes with at least moderate or severe vision loss, respectively, were 59% (53% to 64.5%) and 34% (25% to 43%) at 1 year and 70% (64% to 76%) and 47% (40% to 54%) at 2 to 3 years; the overall pooled estimate of the percentage of eyes developing classic CNV at 1 year was 46% (39% to 54%). Conclusion: A substantial number of patients with occult CNV from AMD will develop at least moderate visual loss at 1 year and severe visual loss within 3 years. However, visual acuity may remain stable in up to 30% of patients. These results may help us to understand the exact role of new therapies and in planning future trials.

AB - Introduction: The purpose of this review is to combine the results of existing literature on the natural history of occult choroidal neovascularisation (CNV) associated with age-related macular degeneration (AMD). Materials and Methods: Published reports evaluating eyes with occult CNV in AMD patients were selected for meta-analysis based on a computerised MEDLINE search. Pooled estimates of the proportions of eyes with a vision loss greater than 2 to 3 (moderate vision loss) or 6 lines (severe vision loss) at 1 year and 2 to 3 years, respectively, or developing a classic component on fluorescein angiography at 1 year were measured. Results: There is no significant heterogeneity among published rates of visual loss and development of classic CNV. The overall pooled estimates (95% confidence limits) of the proportions of eyes with at least moderate or severe vision loss, respectively, were 59% (53% to 64.5%) and 34% (25% to 43%) at 1 year and 70% (64% to 76%) and 47% (40% to 54%) at 2 to 3 years; the overall pooled estimate of the percentage of eyes developing classic CNV at 1 year was 46% (39% to 54%). Conclusion: A substantial number of patients with occult CNV from AMD will develop at least moderate visual loss at 1 year and severe visual loss within 3 years. However, visual acuity may remain stable in up to 30% of patients. These results may help us to understand the exact role of new therapies and in planning future trials.

KW - Age-related maculopathy

KW - Fluorescein angiography

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=33745197122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745197122&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 145

EP - 150

JO - Annals of the Academy of Medicine, Singapore

JF - Annals of the Academy of Medicine, Singapore

SN - 0304-4602

IS - 3

ER -